---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-093965"
form_type: "8-K"
ticker: "HYPR"
cik: "0001833769"
company_name: "Hyperfine, Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T11:12:38.741688+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Hyperfine Q2 revenue record $3.63M, raises FY 2024 guidance to $13-16M

## Summary
- Record Q2 revenue $3.63M (+7.4% YoY); 13 commercial Swoop systems sold.
- Gross margin improved to 49.6% vs 42.7% YoY; net loss $0.14 per share.
- Raised FY 2024 revenue guidance to $13-16M (prior $12-15M), ~31% YoY growth midpoint.
- Cash burn guidance unchanged at ~$40M for full year 2024.
- FDA cleared 9th gen AI brain imaging software; initiated CARE PMR Alzheimer's study.

## SEC filing metadata
- accession: 0000950170-24-093965
- form_type: 8-K
- ticker: HYPR
- cik: 0001833769
- company_name: Hyperfine, Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833769/000095017024093965/0000950170-24-093965-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833769/000095017024093965/hypr-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-093965
- JSON: https://secwatch.observer/filing/0000950170-24-093965.json
- Plain text: https://secwatch.observer/filing/0000950170-24-093965.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.